SCHEMBL14101005

SCHEMBL14101005

Cc1ccc(-c2ccc3c(ccc4cc(Oc5cccc6ccccc56)ccc43)c2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 2/20 0.41
RCE1 Q9Y256 1/20 0.41
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2B6 P20813 1/20 0.40
MCL1 Q07820 2/20 0.37
KDR P35968 1/20 0.36
TLR8 Q9NR97 1/20 0.36
CYP2A6 P11509 2/20 0.36
CNR2 P34972 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101031 0.85 ALDH1A1 (0.38) CYP1A2ALDH1A1HPGDHSD17B10GAA
SCHEMBL14101020 0.81 GAA (0.34) CYP1A2ALDH1A1GAARCE1MCL1
SCHEMBL5746859 0.81 CYP1A2 (0.50) CYP1A2ALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL14101004 0.77 PPARG (0.42) CYP1A2ALDH1A1HPGDGAARCE1
SCHEMBL14101009 0.77 PPARG (0.40) CYP1A2ALDH1A1GAARCE1CYP2C9
SCHEMBL443820 0.76 GAA (0.61) CYP1A2ALDH1A1HPGDHSD17B10GAA
SCHEMBL30731587 0.76 GAA (0.61) CYP1A2ALDH1A1HPGDHSD17B10GAA
SCHEMBL14101019 0.75 MCL1 (0.36) ALDH1A1GAACYP2C9CYP2C19MCL1
SCHEMBL28440233 0.74 GAA (0.55) CYP1A2ALDH1A1HPGDHSD17B10GAA
SCHEMBL13829351 0.73 ESR1 (0.47) HPGDGAARCE1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166593-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
US-20080166593-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166593-A1 Organic Electroluminescent Devices OR10J3, DDT, EML4 CYP1A2 870/4885ALDH1A1 610/4885HPGD 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.